As of 2025-09-18, the Fair Value of SkinBioTherapeutics PLC (SBTX.L) is -5.48 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 16.50 GBP, the upside of SkinBioTherapeutics PLC is -133.22%.
With the market price of 16.50 GBP and our fair value calculation, SkinBioTherapeutics PLC (SBTX.L) is not a good investment. Investing in SBTX.L stocks now will result in a potential loss of 133.22%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 5Y Avg | |
| Net income | -1.50 | -1.43 | -2.79 | -2.84 | -2.88 | -2.29 |
| YoY growth | -30.66% | 4.47% | -94.88% | -1.52% | -1.44% | -24.81% |
| Market Cap (mil) | 38.76 |
| P/E | |
| Forward P/E |
| EPS | -1.10 |
| Avg earnings growth rate | -24.81% |
| TTM earnings | -2.58 |